Epidemiology, molecular characterization and antibiotic resistance of neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Ibarz Pavón, Ana Belén ^a,b,c   Morais, Luis ^b   Sigaúque, Betuel ^a,b   Mandomando, Inacio ^b,d   Bassat, Quique ^a,b   Nhacolo, Ariel ^b   Quintó, Llorenç ^a   Soriano Gabarró, Montse ^e   Alonso, Pedro L ^a,b   Roca, Anna ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD GROUP TYPING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC ANALYSIS; HEALTH SURVEY; HOSPITALIZED CHILD; HUMAN; INCIDENCE; MENINGOCOCCOSIS; MOLECULAR EPIDEMIOLOGY; MOZAMBIQUE; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; BACTEREMIA; BODY FLUID; CLASSIFICATION; GENETICS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; RURAL POPULATION; SEROTYPING; STATISTICS;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

ADOLESCENT; BACTEREMIA; BODY FLUIDS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; INFANT; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; MOZAMBIQUE; NEISSERIA MENINGITIDIS; RURAL POPULATION; SEROTYPING;

EID: 79958710632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019717     Document Type: Article

References (43)

1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. N Engl J Med 344: 1378-1388.
2. Miller E, Salisbury D, Ramsay M, (2001) Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20 (Suppl 1): S58-67.
3. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME, (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364: 365-367.
4. Okoko BJ, Idoko OT, Adegbola RA, (2009) Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa. Vaccine 27: 2023-2029.
5. Campagne G, Chippaux JP, Djibo S, Issa O, Garba A, (1999) [Epidemiology and control of bacterial meningitis in children less than 1 year in Niamey (Niger)]. Bull Soc Pathol Exot 92: 118-122.
6. Harrison LH, Trotter CL, Ramsay ME, (2009) Global epidemiology of meningococcal disease. Vaccine 27 (Suppl 2): B51-63.
7. LaForce M, Ravenscroft N, Djingarey M, Viviani S, (2009) Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Vaccine 27 (Suppl 2): B13-19.
8. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, et al. (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356: 2159.
9. Taha MK, Parent Du Chatelet I, Schlumberger M, Sanou I, Djibo S, et al. (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40: 1083-1084.
10. Traore Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 43: 817-822.
11. Njanpop-Lafourcade BM, Parent du Chatelet I, Sanou O, Alonso JM, Taha MK, (2005) The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes Infect 7: 645-649.
12. Gagneux S, Wirth T, Hodgson A, Ehrhard I, Morelli G, et al. (2002) Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis 8: 462-466.
13. Djibo S, (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Trop Med Int Health 8: 1118-1123.
14. Mutonga DM, Pimentel G, Muindi J, Nzioka C, Mutiso J, et al. (2009) Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. Am J Trop Med Hyg 80: 619-624.
15. Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, et al. (2002) Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 96: 242-249.
16. Cuevas LE, Jeanne I, Molesworth A, Bell M, Savory EC, et al. (2007) Risk mapping and early warning systems for the control of meningitis in Africa. Vaccine 25 (Suppl 1): A12-17.
17. Thomson MC, Molesworth AM, Djingarey MH, Yameogo KR, Belanger F, et al. (2006) Potential of environmental models to predict meningitis epidemics in Africa. Trop Med Int Health 11: 781-788.
18. Molesworth AM, Cuevas LE, Connor SJ, Morse AP, Thomson MC, (2003) Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 9: 1287-1293.
19. Jani JV, Jani IV, Araujo C, Sahay S, Barreto J, et al. (2006) Assessment of routine surveillance data as a tool to investigate measles outbreaks in Mozambique. BMC Infect Dis 6: 29.
20. Snape MD, Kelly DF, Salt P, Green S, Snowden C, et al. (2006) Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin Infect Dis 43: 1387-1394.
21. Roca A, Bassat Q, Morais L, Machevo S, Sigauque B, et al. (2009) Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique. Clin Infect Dis 48 (Suppl 2): S172-180.
22. Roca A, Quinto l, Abacassamo F, Morais L, Valles X, et al. (2008) Invasive Haemophilus influenzae disease in childre <5 years of age in Manhiça, a rural area of southern. Mozambique.
23. Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, et al. (2008) A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 3: e1934.
24. Zimba TF, Nota DT, Langa JC, Monteiro LG, Coovadia YM, (2009) The aetiology of acute community acquired bacterial meningitis in children and adults in Maputo, Mozambique. J Infect Dev Ctries 3: 723-726.
25. Alonso PL, Saúte F, Aponte JJ, Gómez-Olivé FX, Nhacolo A, (2011) Manhiça Demographic Surveillance System, Mozambique. http://www.indepth-network.org/dss_site_profiles/manhicadss.pdf.
26. Naniche D, Bardaji A, Lahuerta M, Berenguera A, Mandomando I, et al. (2009) Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg 80: 870-876.
27. Sigauque B, Roca A, Sanz S, Oliveiras I, Martinez M, et al. (2008) Acute bacterial meningitis among children, in Manhica, a rural area in Southern Mozambique. Acta Trop 105: 21-27.
28. Taha MK, (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38: 855-857.
29. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
30. Fox AJ, Taha MK, Vogel U, (2007) Standardized nonculture techniques recommended for European reference laboratories. FEMS Microbiol Rev 31: 84-88.
31. Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, et al. (2000) Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 38: 2311-2316.
32. Parent du Chatelet I, Traore Y, Gessner BD, Antignac A, Naccro B, et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 40: 17-25.
33. von Gottberg A, du Plessis M, Cohen C, Prentice E, Schrag S, et al. (2008) Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 46: 377-386.
34. Decosas J, (2002) Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2: 763-765.
35. Forgor AA, Leimkugel J, Hodgson A, Bugri A, Dangy JP, et al. (2005) Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health 10: 1229-1234.
36. Coulson GB, von Gottberg A, du Plessis M, Smith AM, de Gouveia L, et al. (2007) Meningococcal disease in South Africa, 1999-2002. Emerg Infect Dis 13: 273-281.
37. Peltola H, (2001) Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention. Clin Infect Dis 32: 64-75.
38. Sacarlal J, Nhacolo AQ, Sigauque B, Nhalungo DA, Abacassamo F, et al. (2009) A 10 year study of the cause of death in children under 15 years in Manhica, Mozambique. BMC Public Health 9: 67.
39. MacLennan JM, Urwin R, Obaro S, Griffiths D, Greenwood B, et al. (2000) Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? Lancet 356: 1078.
40. Mueller JE, Sangare L, Njanpop-Lafourcade BM, Tarnagda Z, Traore Y, et al. (2007) Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. Emerg Infect Dis 13: 847-854.
41. Nicolas P, Djibo S, Tenebray B, Castelli P, Stor R, et al. (2007) Populations of pharyngeal meningococci in Niger. Vaccine 25 (Suppl 1): A53-57.
42. Fiorito SM, Galarza PG, Sparo M, Pagano EI, Oviedo CI, (2001) An unusual transmission of Neisseria meningitidis: neonatal conjunctivitis acquired at delivery from the mother's endocervical infection. Sex Transm Dis 28: 29-32.
43. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP, (2008) Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J Clin Microbiol 46: 3208-3214.